Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Redmile Group, Llc Insider Profile
11 Followers
Redmile Group, Llc, Ten Percent Owner at Array Biopharma, holds 2.96M shares in IGM Biosciences (Ticker: IGMS), holds 12.88M shares in Fate Therapeutics (Ticker: FATE), holds 28.81M shares in ADC Therapeutics (Ticker: ADCT).
Redmile Group, Llc Array Biopharma (~ARRY)Ten Percent Owner
Array Biopharma (~ARRY)
Ten Percent Owner
Ranked #19,708 out of 100,270 Corporate Insiders
Profitable Transactions
18 out of 44 Profitable Transactions
Average Return
+2.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Redmile Group, Llc's holdings
Insider Roles
Roles that Redmile Group, Llc holds in companies
Most Profitable Insider Trade
The most profitable trade made by Redmile Group, Llc
Redmile Group, Llc's Trading History
Array Biopharma
Sep 30, 2016
―
Informative Sell
15.85M
$916.36M
Amicus
Jun 13, 2016
Ten Percent Owner
Informative Buy
―
$119.88M
Alder Biopharmaceuticals
Oct 24, 2019
―
Uninformative Sell
―
$0.00
Xeris Pharmaceuticals
Feb 21, 2019
Ten Percent Owner
Informative Buy
5.88M
$10.62M
Allakos
Jul 24, 2018
Ten Percent Owner
Uninformative Buy
―
$1.08M
Replimune Group
Jul 25, 2018
Ten Percent Owner
Uninformative Buy
―
$9.37M
Fate Therapeutics
Dec 26, 2024
Director, Ten Percent Owner
Uninformative Buy
1.82M
$24.09M
Gritstone bio
Oct 03, 2018
Ten Percent Owner
Uninformative Buy
―
$15.34K
Vapotherm
Nov 16, 2018
―
Uninformative Buy
―
$2.08M
TCR2 Therapeutics
Feb 21, 2019
―
Uninformative Buy
―
$1.19M
Hookipa Pharma
Apr 24, 2019
Ten Percent Owner
Uninformative Buy
―
$1.84M
IGM Biosciences
Jan 02, 2025
Director, Ten Percent Owner
Uninformative Buy
―
$19.26M
Cabaletta Bio
Oct 29, 2019
Ten Percent Owner
Uninformative Buy
―
$1.85M
Aprea Therapeutics
Feb 16, 2021
Ten Percent Owner
Informative Sell
2.79M
$7.61M
Atreca
Jun 24, 2019
―
Uninformative Buy
―
$64.38K
Akero Therapeutics
Jun 24, 2019
Ten Percent Owner
Uninformative Buy
―
$20.56M
Stoke Therapeutics
Jun 24, 2019
Ten Percent Owner
Uninformative Buy
―
$7.40M
Beam Therapeutics
Feb 11, 2020
Ten Percent Owner
Uninformative Buy
―
$30.62M
Neurogene
Apr 06, 2020
Ten Percent Owner
Informative Buy
2.01M
$93.43M
Pliant Therapeutics
Jun 09, 2020
Ten Percent Owner
Uninformative Buy
―
$25.18M
Repare Therapeutics
Jun 25, 2020
Ten Percent Owner
Uninformative Buy
―
$2.19M
Nurix Therapeutics
Jul 30, 2020
Ten Percent Owner
Uninformative Buy
―
$22.61M
Annexon Biosciences
Jul 30, 2020
Ten Percent Owner
Uninformative Buy
―
$8.06M
AlloVir
Aug 05, 2020
Ten Percent Owner
Uninformative Buy
―
$388.63K
Kymera Therapeutics
Aug 25, 2020
Ten Percent Owner
Uninformative Buy
―
$65.06M
Shattuck Labs
Dec 06, 2024
Director, Ten Percent Owner
Uninformative Buy
1.28M
$7.04M
Verve Therapeutics
Jun 23, 2021
Ten Percent Owner
Uninformative Buy
―
$12.41M
AbSci
Jun 14, 2024
Director
Uninformative Buy
―
$27.84M
Invivyd
Aug 12, 2021
Ten Percent Owner
Uninformative Buy
―
$1.73M
Science 37
Mar 13, 2024
―
Uninformative Sell
5.85M
$0.00
Augmedix
Oct 04, 2024
―
Uninformative Sell
75.40M
$0.00
Entrada Therapeutics Inc
Nov 04, 2021
Ten Percent Owner
Uninformative Buy
―
$35.28M
MedAvail Holdings
Jul 06, 2022
Director, Ten Percent Owner
Uninformative Buy
18.07M
$73.57M
Zymeworks
Oct 17, 2022
Ten Percent Owner
Uninformative Buy
153.32K
$87.86M
RayzeBio, Inc.
Sep 21, 2023
―
Uninformative Buy
―
$116.09M
ADC Therapeutics
Dec 13, 2024
Ten Percent Owner
Informative Buy
609.00K
$55.90M
List of latest transactions for each holding click on a transaction to see Redmile Group, Llc's performance on stock
You May Also Like
Redmile Group, Llc insider profile FAQ
What is the percentage of profitable transactions made by Redmile Group, Llc?
The percentage of profitable transactions made by Redmile Group, Llc is 41%.
What is the average return per transaction made by Redmile Group, Llc?
The average return per transaction made by Redmile Group, Llc is 2.90%.
What stocks does Redmile Group, Llc hold?
Redmile Group, Llc holds: ~ARRY, FOLD, ALDR, XERS, ALLK, REPL, FATE, GRTSQ, VAPO, TCRR, HOOK, IGMS, CABA, APRE, BCEL, AKRO, STOK, BEAM, NGNE, PLRX, RPTX, NRIX, ANNX, ALVR, KYMR, STTK, VERV, ABSI, IVVD, SNCE, AUGX, TRDA, MDVLQ, ZYME, RYZB, ADCT stocks.
What was Redmile Group, Llc’s latest transaction?
Redmile Group, Llc latest transaction was an Uninformative Buy of ―.
What was Redmile Group, Llc's most profitable transaction?
Redmile Group, Llc’s most profitable transaction was an Informative Buy of FATE stock on June 17, 2020. The return on the trade was 165.20%.
What is Redmile Group, Llc's role in Array Biopharma?
Redmile Group, Llc's role in Array Biopharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.